peptide-drug conjugateOncology Peptides
ANG1005 (Paclitaxel Trevatide)
A peptide-drug conjugate using Angiopep-2 (LRP1-targeting peptide) to cross the blood-brain barrier carrying three paclitaxel molecules. Phase 3 for HER2+ breast cancer brain metastases. Represents targeted BBB-crossing PDC approach.
brain-metastasesBBB-crossingpaclitaxelPDCLRP1-targeting
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A peptide-drug conjugate using Angiopep-2 (LRP1-targeting peptide) to cross the blood-brain barrier carrying three paclitaxel molecules. Phase 3 for HER2+ breast cancer brain metastases. Represents ta…